The authors also observed that Sirt3−/− mouse model reduced graft-versus-host disease (GVHD) severity in comparison to T-cells from control donor mice, which could suggest the ability of Sirt3 to improve the outcome of the transplant [105]. Here, SIRT3 is linked to graft versus host disease.